Drug Trial Radar · NCT05139121
Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
Last checked: Nov 20, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,320
Actual
Start
Oct 26, 2021
Primary completion
Jan 15, 2025
Study completion Jan 15, 2025
Sponsor
- Lead sponsor
- Mylan Technologies Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Mylan Inc.
- First posted
- Dec 1, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 16 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles
Conditions
- Contraception
Interventions
MR-100A-01Drug
Transdermal contraceptive delivery system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Contraceptive Efficacy of MR-100A-01 When Used Over Thirteen 28-day Cycles in Healthy, Post-menarcheal, Premenopausal, Heterosexually Active Female Subjects of Childbearing Potential Who Are at Least 16 Years of Age and at Risk of PregnancyTime frame: approximately 12 months (13 cycles with each cycle for 4 weeks)
Locations
100 sites in 3 countries. Site status is shown where the registry gives one.
Mobile Ob-Gyn, P.C.
Mobile, Alabama
Velocity Clinical Research
Mobile, Alabama
Mesa Obstetricians and Gynecologists.
Mesa, Arizona
Precision Trials AZ
Phoenix, Arizona
Visions Clinical Research Tucson
Tucson, Arizona
Alliance Research Institute
Bell Gardens, California
Essential Access Health
Berkeley, California
Velocity Clinical Research - Huntington Park
Huntington Park, California
Essential Access Health
Los Angeles, California
Axis Clinical Trials
Los Angeles, California
Matrix Clinical Research
Los Angeles, California
Velocity Clinical Research - Gardena
Los Angeles, California
Velocity Clinical Research, Panorama City
Los Angeles, California
Stanford University, School of Medicine, Department of Obstetrics and Gynecology
Palo Alto, California
Empire Clinical Research
Pomona, California
Northern California Research Corp
Sacramento, California
Women's Health Care Research Corp.
San Diego, California
Wr-McCr, Llc
San Diego, California
Amicis Research Center
San Fernando, California
Red Rocks Ob-Gyn
Lakewood, Colorado
IntimMedicine Specialists
Washington D.C., District of Columbia
Quantum Clinical Trials
Boynton Beach, Florida
Aventura OB/GYN Associates
Hallandale, Florida
CenExel RCA
Hollywood, Florida
Global Research Associates
Homestead, Florida
UF Health Woman's Specialist - Emerson
Jacksonville, Florida
Multi-Specialty Research Associates
Lake City, Florida
WR-Multi-Specialty Research Associates LLC
Lake City, Florida
Altus Research
Lake Worth, Florida
Ob-Gyn Associates Of Mid-Florida, PA
Leesburg, Florida
Advanced Pharma CR LLC
Miami, Florida
Avantis Clinical Research
Miami, Florida
AdMed Research, LLC
Miami, Florida
New Age Medical Research Corporation
Miami, Florida
ProCare Research Center, Corp.
Miami Gardens, Florida
Global Health Research Center
Miami Lakes, Florida
Suncoast Clinical Research, Inc.
New Port Richey, Florida
Healthcare Clinical Data, Inc. - Segal Institute for Clinica
North Miami, Florida
Clintheory Healthcare Miami
Orlando, Florida
Physician Care Clinical Research
Sarasota, Florida
Showing 40 of 100 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.